Sandra T Yeh, MD
Dermatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 8 carriers
- Office
- 1
Offices
1 location
Looking this up.
Plans that list them
32 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yeh’s office at (408) 246-8900 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A82081 · Current
Licensed to practise in California · since 2003 · expires 2029-01-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$82,826
Medicare paid this office $82,826 for 267 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Destruction of skin growth, 1-14 growths | 174 | $28,175 | $96 |
| Short return visit (20+ min) | 199 | $23,866 | $68 |
| New patient visit (30+ min) | 81 | $5,680 | $70 |
| Destruction of growth of eyelid margin, 1.0 cm or less | 16 | $3,466 | $193 |
| Destruction of skin growth, 15 or more growths | 18 | $2,838 | $105 |
See all 10 services
| Destruction of skin growth, 1-14 growths | 174 | $28,175 | $96 |
| Short return visit (20+ min) | 199 | $23,866 | $68 |
| New patient visit (30+ min) | 81 | $5,680 | $70 |
| Destruction of growth of eyelid margin, 1.0 cm or less | 16 | $3,466 | $193 |
| Destruction of skin growth, 15 or more growths | 18 | $2,838 | $105 |
| Destruction of precancer skin growth, 1 growth | 51 | $2,772 | $29 |
| Biopsy of related skin growth, first growth | 40 | $2,632 | $53 |
| Destruction of precancer skin growth, 2-14 growths | 51 | $1,615 | $6 |
| Injection into skin growth, 1-7 growths | 37 | $1,451 | $28 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 37 | $37 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 39 | More than 84% of doctors who do this |
| Removal of skin lesions | 663 | More than 89% of doctors who do this |
| Skin biopsy | 113 | More than 77% of doctors who do this |
Who their Medicare patients are
267 Original Medicare patients in 2024. Average age 74 · Women 56% · Health risk score 0.70. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 62% · Diabetes 25% · Coronary heart disease 20% · Cancer 12% · Chronic kidney disease 11% · Atrial fibrillation 7% · Depression 6% · Heart failure 4% · Stroke 4%.
The office billed $240,925, Medicare allowed $119,775 and paid $82,826; for 1,380 services of 26 kinds; $37 of it was for drugs given in the office and $82,789 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 267 | 1,380 | 74 | 0.70 | $240,925 | $82,826 |
| 2023 | 256 | 1,378 | 74 | 0.73 | $236,750 | $90,254 |
| 2022 | 241 | 1,332 | 73 | 0.69 | $218,000 | $76,478 |
| 2021 | 228 | 1,430 | 73 | 0.74 | $229,005 | $86,636 |
| 2020 | 179 | 1,107 | 73 | 0.84 | $174,020 | $59,377 |
| 2019 | 220 | 1,215 | 72 | 0.73 | $201,105 | $70,614 |
| 2018 | 206 | 1,179 | 73 | 0.72 | $172,790 | $57,727 |
| 2017 | 194 | 999 | 73 | 0.81 | $171,340 | $63,316 |
| 2016 | 165 | 1,043 | 73 | 0.83 | $138,305 | $52,686 |
| 2015 | 156 | 1,166 | 73 | 0.77 | $141,525 | $52,651 |
| 2014 | 174 | 1,217 | 74 | 0.91 | $141,960 | $55,923 |
| 2013 | 164 | 1,061 | 73 | 0.88 | $126,235 | $52,613 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Destruction of skin growth, 1-14 growths | 177 | $30,628 | $107 |
| Short return visit (20+ min) | 185 | $22,078 | $76 |
| New patient visit (30+ min) | 74 | $6,502 | $88 |
| Destruction of growth of eyelid margin, 1.0 cm or less | 22 | $4,994 | $217 |
| Destruction of precancer skin growth, 1 growth | 70 | $3,902 | $33 |
| Destruction of skin growth, 15 or more growths | 16 | $3,527 | $126 |
| Biopsy of related skin growth, first growth | 45 | $3,294 | $62 |
| Destruction of precancer skin growth, 2-14 growths | 61 | $2,104 | $7 |
| Return visit (30+ min) | 16 | $1,622 | $95 |
| Injection into skin growth, 1-7 growths | 42 | $1,570 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 48 | $46 | None |
2022: 11 services
| Destruction of skin growth, 1-14 growths | 159 | $27,777 | $104 |
| Short return visit (20+ min) | 136 | $13,457 | $73 |
| New patient visit (30+ min) | 73 | $5,793 | $79 |
| Destruction of precancer skin growth, 1 growth | 77 | $4,506 | $31 |
| Biopsy of related skin growth, first growth | 58 | $3,583 | $53 |
| Destruction of precancer skin growth, 2-14 growths | 74 | $2,299 | $7 |
| Destruction of skin growth, 15 or more growths | 13 | $1,620 | $108 |
| Return visit (30+ min) | 15 | $1,593 | $100 |
| Injection into skin growth, 1-7 growths | 35 | $1,424 | $27 |
| Biopsy of related skin growth, each additional growth | 13 | $962 | $53 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 38 | $43 | None |
2021: 10 services
| Destruction of skin growth, 1-14 growths | 161 | $33,139 | $111 |
| Short return visit (20+ min) | 140 | $14,443 | $77 |
| New patient visit (30+ min) | 71 | $5,853 | $82 |
| Destruction of growth of eyelid margin, 1.0 cm or less | 16 | $4,625 | $231 |
| Destruction of precancer skin growth, 1 growth | 75 | $4,558 | $32 |
| Biopsy of related skin growth, first growth | 62 | $4,419 | $59 |
| Destruction of precancer skin growth, 2-14 growths | 70 | $2,767 | $7 |
| Biopsy of related skin growth, each additional growth | 23 | $1,807 | $55 |
| Injection into skin growth, 1-7 growths | 30 | $1,298 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 34 | $36 | None |
2020: 10 services
| Destruction of skin growth, 1-14 growths | 120 | $21,595 | $100 |
| Short return visit (20+ min) | 99 | $7,907 | $60 |
| Destruction of growth of eyelid margin, 1.0 cm or less | 14 | $4,373 | $219 |
| Destruction of precancer skin growth, 1 growth | 62 | $3,664 | $32 |
| Biopsy of related skin growth, first growth | 53 | $3,405 | $55 |
| New patient visit (30+ min) | 41 | $3,138 | $77 |
| Destruction of precancer skin growth, 2-14 growths | 59 | $2,155 | $6 |
| Biopsy of related skin growth, each additional growth | 17 | $1,153 | $52 |
| Injection into skin growth, 1-7 growths | 31 | $1,061 | $27 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 34 | $46 | None |
2019: 10 services
| Destruction of skin growth, 1-14 growths | 159 | $28,556 | $104 |
| Short return visit (20+ min) | 114 | $10,419 | $65 |
| New patient visit (30+ min) | 71 | $5,696 | $80 |
| Biopsy of related skin growth, first growth | 64 | $4,220 | $56 |
| Destruction of precancer skin growth, 1 growth | 75 | $4,128 | $32 |
| Destruction of growth of eyelid margin, 1.0 cm or less | 14 | $2,984 | $213 |
| Destruction of precancer skin growth, 2-14 growths | 72 | $1,701 | $6 |
| Injection into skin growth, 1-7 growths | 38 | $1,566 | $33 |
| Biopsy of related skin growth, each additional growth | 12 | $910 | $54 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 39 | $62 | None |
2018: 9 services
| Destruction of skin growth, 1-14 growths | 162 | $28,271 | $104 |
| Short return visit (20+ min) | 116 | $8,907 | $58 |
| Biopsy of single growth of skin and/or tissue | 60 | $4,167 | $55 |
| Destruction of precancer skin growth, 1 growth | 67 | $4,082 | $32 |
| New patient visit (30+ min) | 60 | $3,849 | $64 |
| Destruction of precancer skin growth, 2-14 growths | 62 | $1,763 | $5 |
| Injection into skin growth, 1-7 growths | 26 | $1,072 | $28 |
| Biopsy of each additional growth of skin and/or tissue | 20 | $776 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $52 | None |
2017: 9 services
| Destruction of skin growth, 1-14 growths | 146 | $22,746 | $102 |
| Short return visit (20+ min) | 132 | $11,761 | $60 |
| Biopsy of single growth of skin and/or tissue | 66 | $5,715 | $66 |
| New patient visit (30+ min) | 62 | $5,457 | $88 |
| Destruction of precancer skin growth, 1 growth | 58 | $3,281 | $33 |
| Biopsy of each additional growth of skin and/or tissue | 20 | $1,136 | $31 |
| Destruction of precancer skin growth, 2-14 growths | 52 | $960 | $5 |
| Injection into skin growth, 1-7 growths | 20 | $837 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $36 | None |
2016: 9 services
| Short return visit (20+ min) | 132 | $13,125 | $59 |
| Destruction of skin growth, 1-14 growths | 85 | $12,880 | $104 |
| Biopsy of single growth of skin and/or tissue | 56 | $5,591 | $80 |
| Destruction of precancer skin growth, 1 growth | 62 | $4,410 | $43 |
| New patient visit (30+ min) | 48 | $4,142 | $86 |
| Destruction of precancer skin growth, 2-14 growths | 54 | $1,819 | $5 |
| Biopsy of each additional growth of skin and/or tissue | 23 | $1,163 | $31 |
| Injection into skin growth, 1-7 growths | 17 | $760 | $32 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $34 | None |
2015: 9 services
| Short return visit (20+ min) | 108 | $9,920 | $58 |
| Destruction of skin growth, 1-14 growths | 71 | $9,540 | $103 |
| Biopsy of single growth of skin and/or tissue | 63 | $6,838 | $78 |
| Destruction of precancer skin growth, 1 growth | 63 | $3,971 | $39 |
| New patient visit (30+ min) | 39 | $3,479 | $89 |
| Destruction of precancer skin growth, 2-14 growths | 59 | $2,224 | $5 |
| Biopsy of each additional growth of skin and/or tissue | 30 | $1,451 | $29 |
| Injection into skin growth, 1-7 growths | 17 | $652 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $35 | None |
2014: 9 services
| Short return visit (20+ min) | 108 | $10,499 | $63 |
| Destruction of skin growth, 1-14 growths | 62 | $7,956 | $97 |
| Biopsy of single growth of skin and/or tissue | 69 | $7,448 | $84 |
| Destruction of precancer skin growth, 1 growth | 65 | $6,029 | $53 |
| Destruction of precancer skin growth, 2-14 growths | 61 | $5,003 | $10 |
| New patient visit (30+ min) | 45 | $3,448 | $77 |
| Biopsy of each additional growth of skin and/or tissue | 33 | $1,815 | $29 |
| Injection into skin growth, 1-7 growths | 14 | $552 | $34 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $28 | None |
2013: 10 services
| Destruction of skin growth, 1-14 growths | 60 | $9,216 | $107 |
| Short return visit (20+ min) | 97 | $8,695 | $62 |
| Biopsy of single growth of skin and/or tissue | 60 | $7,448 | $85 |
| Destruction of precancer skin growth, 1 growth | 53 | $4,633 | $56 |
| New patient visit (30+ min) | 50 | $3,949 | $79 |
| Destruction of precancer skin growth, 15 or more growths | 12 | $3,219 | $161 |
| Destruction of precancer skin growth, 2-14 growths | 48 | $2,361 | $6 |
| Biopsy of each additional growth of skin and/or tissue | 27 | $1,525 | $30 |
| Injection into skin growth, 1-7 growths | 11 | $429 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $25 | None |
Drugs they prescribed that Part D paid
$104,144
Pharmacies billed $104,144 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 267) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
245 generic and 22 brand-name prescriptions · $104,144 in drug cost · 13 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clobetasol Propionate | 19 | $1,100 | $58 |
| Ketoconazole | 18 | $559 | $31 |
| Permethrin | 13 | $409 | $31 |
| Triamcinolone Acetonide | 57 | $328 | $6 |
| Hydroxyzine | 17 | $278 | $16 |
See all 6 drugs
| Clobetasol Propionate | 19 | $1,100 | $58 |
| Ketoconazole | 18 | $559 | $31 |
| Permethrin | 13 | $409 | $31 |
| Triamcinolone Acetonide | 57 | $328 | $6 |
| Hydroxyzine | 17 | $278 | $16 |
| Hydrocortisone | 25 | $120 | $5 |
Year by year
| 2024 | 267 | 111 | 0% (0) | 8% | $104,144 |
| 2023 | 280 | 106 | 0% (0) | None | $58,362 |
| 2022 | 261 | 112 | 0% (0) | None | $42,718 |
| 2021 | 227 | 97 | 0% (0) | 6% | $48,469 |
| 2020 | 240 | 92 | 0% (0) | 5% | $38,235 |
| 2019 | 193 | 91 | 0% (0) | 10% | $50,432 |
| 2018 | 193 | 91 | None | 6% | $36,114 |
| 2017 | 153 | 72 | None | 8% | $10,542 |
| 2016 | 204 | 73 | 0% (0) | 12% | $25,959 |
| 2015 | 203 | 83 | None | None | $26,709 |
| 2014 | 213 | 77 | None | None | $24,898 |
| 2013 | 245 | 76 | 0% (0) | None | $29,765 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Ciclopirox | 12 | $1,791 | $149 |
| Ketoconazole | 31 | $1,475 | $48 |
| Clobetasol Propionate | 18 | $1,451 | $81 |
| Doxycycline Hyclate | 20 | $975 | $49 |
| Doxepin | 14 | $747 | $53 |
| Hydroxyzine | 19 | $740 | $39 |
| Triamcinolone Acetonide | 50 | $639 | $13 |
| Cephalexin | 13 | $122 | $9 |
| Hydrocortisone | 13 | $87 | $7 |
2022: 5 drugs
| Clobetasol Propionate | 26 | $2,433 | $94 |
| Ketoconazole | 30 | $2,051 | $68 |
| Doxycycline Hyclate | 23 | $1,470 | $64 |
| Triamcinolone Acetonide | 44 | $298 | $7 |
| Hydrocortisone | 26 | $206 | $8 |
2021: 6 drugs
| Doxycycline Hyclate | 13 | $1,299 | $100 |
| Clobetasol Propionate | 21 | $1,233 | $59 |
| Ketoconazole | 26 | $1,020 | $39 |
| Triamcinolone Acetonide | 49 | $334 | $7 |
| Prednisone | 16 | $150 | $9 |
| Hydrocortisone | 18 | $89 | $5 |
2020: 6 drugs
| Clobetasol Propionate | 23 | $1,117 | $49 |
| Ketoconazole | 22 | $711 | $32 |
| Triamcinolone Acetonide | 54 | $434 | $8 |
| Hydroxyzine | 11 | $343 | $31 |
| Prednisone | 20 | $155 | $8 |
| Cephalexin | 15 | $87 | $6 |
2019: 4 drugs
| Clobetasol Propionate | 15 | $804 | $54 |
| Ketoconazole | 17 | $797 | $47 |
| Triamcinolone Acetonide | 54 | $392 | $7 |
| Cephalexin | 13 | $77 | $6 |
2018: 4 drugs
| Ketoconazole | 19 | $1,141 | $60 |
| Clobetasol Propionate | 15 | $955 | $64 |
| Doxycycline Hyclate | 12 | $325 | $27 |
| Triamcinolone Acetonide | 35 | $218 | $6 |
2017: 2 drugs
| Clobetasol Propionate | 25 | $2,479 | $99 |
| Triamcinolone Acetonide | 23 | $170 | $7 |
2016: 7 drugs
| Clobetasol Propionate | 45 | $5,702 | $127 |
| Econazole Nitrate | 21 | $5,279 | $251 |
| Calcipotriene | 11 | $3,183 | $289 |
| Betamethasone Dipropionate | 18 | $2,052 | $114 |
| Doxycycline Hyclate | 14 | $778 | $56 |
| Ketoconazole | 12 | $515 | $43 |
| Triamcinolone Acetonide | 14 | $133 | $9 |
2015: 3 drugs
| Clobetasol Propionate | 50 | $8,221 | $164 |
| Econazole Nitrate | 23 | $6,403 | $278 |
| Triamcinolone Acetonide | 14 | $140 | $10 |
2014: 3 drugs
| Clobetasol Propionate | 38 | $4,726 | $124 |
| Econazole Nitrate | 29 | $1,888 | $65 |
| Triamcinolone Acetonide | 25 | $219 | $9 |
2013: 7 drugs
| Betamethasone Dipropionate | 15 | $1,616 | $108 |
| Clobetasol Propionate | 35 | $1,554 | $44 |
| Econazole Nitrate | 26 | $944 | $36 |
| Ketoconazole | 18 | $415 | $23 |
| Doxepin | 13 | $380 | $29 |
| Hydrocortisone | 16 | $249 | $16 |
| Triamcinolone Acetonide | 20 | $220 | $11 |
Money from drug and device companies
$1,477 in 2025
| 2025 | 14 | 55 | None | $1,477 |
| 2024 | 10 | 47 | None | $1,210 |
| 2023 | 12 | 50 | None | $1,234 |
| 2022 | 13 | 62 | None | $1,460 |
| 2021 | 17 | 79 | None | $1,707 |
| 2020 | 15 | 60 | None | $1,257 |
| 2019 | 20 | 77 | None | $1,274 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $353 | 15 payments
|
| Regeneron Healthcare Solutions | Dupixent | $300 | 10 payments
|
| Galderma Laboratories L.P. | Nemluvio | $209 | 8 payments
|
| Genzyme | Dupixent | $164 | 5 payments
|
| Novartis Pharmaceuticals | Cosentyx | $86 | 3 payments
|
| Organon | Vtama | $69 | 3 payments
|
See all 55 published payments
| Regeneron Healthcare Solutions | Meals · 2025-12-20 | Dupixent | $29 |
| Abbvie | Meals · 2025-12-08 | Rinvoq | $27 |
| Organon | Meals · 2025-12-05 | None | $28 |
| Incyte | Meals · 2025-12-02 | Opzelura | $15 |
| Journey Medical | Meals · 2025-11-24 | None | $24 |
| LEO Pharma | Meals · 2025-11-21 | Adbry | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-11-19 | Dupixent | $28 |
| Genzyme | Meals · 2025-11-14 | Dupixent | $33 |
| Novartis Pharmaceuticals | Meals · 2025-11-11 | Cosentyx | $29 |
| Abbvie | Meals · 2025-11-06 | Rinvoq | $25 |
| LEO Pharma | Meals · 2025-10-28 | Anzupgo | $30 |
| Regeneron Healthcare Solutions | Meals · 2025-10-25 | Dupixent | $17 |
| Abbvie | Meals · 2025-10-17 | Rinvoq | $9 |
| Genzyme | Meals · 2025-10-17 | Dupixent | $31 |
| Galderma Laboratories L.P. | Meals · 2025-10-10 | Nemluvio | $23 |
| Abbvie | Meals · 2025-10-03 | Skyrizi | $25 |
| Regeneron Healthcare Solutions | Meals · 2025-09-27 | Dupixent | $26 |
| Abbvie | Meals · 2025-09-24 | Rinvoq | $24 |
| Janssen Biotech | Meals · 2025-09-17 | Tremfya | $24 |
| Galderma Laboratories L.P. | Meals · 2025-09-12 | Nemluvio | $23 |
| Novartis Pharmaceuticals | Meals · 2025-09-02 | Cosentyx | $28 |
| Novartis Pharmaceuticals | Meals · 2025-09-02 | Cosentyx | $28 |
| Abbvie | Meals · 2025-08-28 | Skyrizi | $29 |
| Regeneron Healthcare Solutions | Education · 2025-08-27 | Dupixent | $74 |
| Galderma Laboratories L.P. | Meals · 2025-08-27 | None | $29 |
| Abbvie | Meals · 2025-08-22 | Rinvoq | $11 |
| Genzyme | Meals · 2025-08-22 | Dupixent | $35 |
| Abbvie | Meals · 2025-07-31 | Rinvoq | $27 |
| Galderma Laboratories L.P. | Meals · 2025-07-25 | Nemluvio | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-07-19 | Dupixent | $30 |
| Regeneron Healthcare Solutions | Meals · 2025-06-28 | Dupixent | $28 |
| Abbvie | Meals · 2025-06-14 | Rinvoq | $26 |
| Galderma Laboratories L.P. | Meals · 2025-05-28 | Nemluvio | $33 |
| Sun Pharmaceutical Industries | Meals · 2025-05-23 | Winlevi | $27 |
| Genzyme | Meals · 2025-05-20 | Dupixent | $33 |
| Abbvie | Meals · 2025-05-13 | Skyrizi | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-05-10 | Dupixent | $10 |
| Galderma Laboratories L.P. | Meals · 2025-05-07 | Nemluvio | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-04-15 | Dupixent | $31 |
| Incyte | Meals · 2025-04-15 | Opzelura | $28 |
| Abbvie | Meals · 2025-04-09 | Rinvoq | $29 |
| Abbvie | Meals · 2025-04-08 | Skyrizi | $27 |
| Galderma Laboratories L.P. | Meals · 2025-03-15 | Nemluvio | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-03-12 | Dupixent | $28 |
| Abbvie | Meals · 2025-03-05 | Rinvoq | $21 |
| Sun Pharmaceutical Industries | Meals · 2025-02-28 | Winlevi | $29 |
| Pfizer | Meals · 2025-02-25 | Eucrisa | $26 |
| Organon | Meals · 2025-02-25 | Vtama | $8 |
| Astellas Pharma US | Meals · 2025-02-19 | Izervay | $32 |
| Abbvie | Meals · 2025-02-07 | Skyrizi | $23 |
| Galderma Laboratories L.P. | Meals · 2025-01-28 | Nemluvio | $8 |
| Lilly USA | Meals · 2025-01-24 | Taltz | $31 |
| Organon | Meals · 2025-01-14 | Vtama | $33 |
| Abbvie | Meals · 2025-01-11 | Rinvoq | $28 |
| Genzyme | Meals · 2025-01-07 | Dupixent | $32 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,210
| Regeneron Healthcare Solutions | Dupixent | $361 | 14 payments
|
| Abbvie | Skyrizi | $279 | 11 payments
|
| Genzyme | Dupixent | $154 | 7 payments
|
| Pfizer | Eucrisa | $136 | 4 payments
|
| Galderma Laboratories L.P. | None | $81 | 3 payments
|
| Incyte | Opzelura | $75 | 3 payments
|
| LEO Pharma | Adbry | $56 | 2 payments
|
| Janssen Biotech | Tremfya | $27 | 1 payment
|
| Arcutis Biotherapeutics | Zoryve | $24 | 1 payment
|
| Dermavant Sciences | Vtama | $18 | 1 payment
|
2023: $1,234
| Regeneron Healthcare Solutions | Dupixent | $298 | 9 payments
|
| Genzyme | Dupixent | $218 | 11 payments
|
| LEO Pharma | Adbry | $174 | 7 payments
|
| AbbVie | Skyrizi | $143 | 6 payments
|
| Janssen Biotech | Tremfya | $89 | 3 payments
|
| Dermavant Sciences | Vtama | $87 | 4 payments
|
| Amgen | Otezla | $71 | 3 payments
|
| Incyte | Opzelura | $69 | 3 payments
|
| Novartis Pharmaceuticals | None | $24 | 1 payment
|
| Arcutis Biotherapeutics | None | $24 | 1 payment
|
| Pfizer | Eucrisa | $23 | 1 payment
|
| Journey Medical | None | $14 | 1 payment
|
2022: $1,460
| Regeneron Healthcare Solutions | Dupixent | $359 | 12 payments
|
| Abbvie | Rinvoq | $290 | 15 payments
|
| LEO Pharma | Adbry | $278 | 11 payments
|
| Incyte | Opzelura | $121 | 6 payments
|
| Genzyme | Dupixent | $87 | 3 payments
|
| Janssen Biotech | Remicade | $82 | 4 payments
|
| Pfizer | Eucrisa | $58 | 3 payments
|
| Amgen | Otezla | $53 | 2 payments
|
| Journey Medical | Qbrexza | $44 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $30 | 1 payment
|
| Dermavant Sciences | Vtama | $23 | 1 payment
|
| Genentech USA | Xolair | $22 | 1 payment
|
| Sun Pharmaceutical Industries | Absorica Ld | $13 | 1 payment
|
2021: $1,707
| Regeneron Healthcare Solutions | Dupixent | $310 | 10 payments
|
| Sun Pharmaceutical Industries | Absorica Ld | $184 | 12 payments
|
| VYNE Pharmaceuticals | Amzeeq | $184 | 9 payments
|
| LEO Pharma | Enstilar | $172 | 7 payments
|
| Genzyme | Dupixent | $162 | 7 payments
|
| AbbVie | Skyrizi | $146 | 6 payments
|
| Pfizer | Eucrisa | $145 | 8 payments
|
| Mayne Pharma | None | $61 | 3 payments
|
| Galderma Laboratories L.P. | Aklief | $52 | 3 payments
|
| Incyte | Opzelura | $51 | 2 payments
|
| Sanofi-Aventis U.S. | Dupixent | $47 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $46 | 2 payments
|
| EPI Health | Cloderm | $41 | 3 payments
|
| Almirall | Seysara | $38 | 2 payments
|
| Amgen | Enbrel | $27 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $22 | 1 payment
|
| Journey Medical | Targadox | $20 | 1 payment
|
2020: $1,257
| Mayne Pharma | Doryx | $213 | 12 payments
|
| VYNE Pharmaceuticals | Zilxi | $195 | 7 payments
|
| Pfizer | Eucrisa | $147 | 8 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $131 | 8 payments
|
| Regeneron Healthcare Solutions | Dupixent | $124 | 5 payments
|
| EPI Health | Sitavig | $105 | 1 payment
|
| Galderma Laboratories L.P. | Aklief | $68 | 4 payments
|
| Genzyme | Dupixent | $65 | 3 payments
|
| Journey Medical | Targadox | $52 | 3 payments
|
| Janssen Biotech | Tremfya | $50 | 2 payments
|
| Almirall | Seysara | $47 | 3 payments
|
| Sun Pharmaceutical Industries | Absorica Ld | $23 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $20 | 1 payment
|
| LEO Pharma | Finacea | $11 | 1 payment
|
| Biofrontera | Ameluz | $5 | 1 payment
|
2019: $1,274
| Pfizer | Eucrisa | $290 | 25 payments
|
| Mayne Pharma | Doryx | $222 | 13 payments
|
| Regeneron Healthcare Solutions | Dupixent | $192 | 8 payments
|
| EPI Health | Sitavig | $122 | 6 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $112 | 6 payments
|
| Genzyme | Dupixent | $43 | 2 payments
|
| AbbVie | Humira | $38 | 2 payments
|
| Galderma Laboratories L.P. | Epiduo Forte | $30 | 2 payments
|
| Taro Pharmaceuticals USA | Halog | $24 | 1 payment
|
| Mission Pharmacal | Ovace | $23 | 2 payments
|
| LEO Pharma | Enstilar | $21 | 1 payment
|
| Sun Pharmaceutical Industries | Absorica | $21 | 1 payment
|
| Dermira | None | $20 | 1 payment
|
| Promius Pharma | Sernivo | $20 | 1 payment
|
| Journey Medical | Exelderm | $18 | 1 payment
|
| Biofrontera | Ameluz | $18 | 1 payment
|
| Amgen | Otezla | $18 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $18 | 1 payment
|
| Mylan Pharmaceuticals | Olux | $14 | 1 payment
|
| Almirall | Seysara | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1366477606
- Licence
- CA A82081California A82081: Current · expires 2029-01-31
- Trained
- University of California, San Diego School of Medicine, 1999
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 706 N Winchester Blvd, San Jose, CA, 95128
- NPI first listed
- 2006-07-12
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.